LATEST ALERTS
South Carolina regulatory snapshot, August 2019
30th August 2019 - Regulatory reports |
Our latest updates on the regulations regarding South Carolina’s laws around growing, processing and import and export of CBD products can be found here
Regulation and legislation
Georgia regulatory snapshot, August 2019
30th August 2019 - Regulatory reports |
CBD end-products with no more than 0.3% THC are within the regulations of the law in Georgia, providing they are not added to foodstuff. This report provides details
CBD drug Epidyolex looks unlikely to get a NICE answer in the UK
29th August 2019 - News analysis |
The panel largely responsible for recommending which drugs the UK’s National Health Service (NHS) should provide may discourage use of the CBD-based drug Epidyolex
Connecticut regulatory snapshot, August 2019
29th August 2019 - Regulatory reports |
State regulations for Connecticut relating to permits, processing, import and export of CBD products are outlined here
New Jersey regulatory snapshot, August 2019
28th August 2019 - Regulatory reports |
Hemp products not exceeding the federal limit of 0.3% THC content are explicitly legal in New Jersey. This report provides details
Pennsylvania regulatory snapshot, August 2019
26th August 2019 - Regulatory reports |
Pennsylvania is one of the US states that has implemented the 2018 federal Farm Bill, and distinguishes between industrial hemp and marijuana
Greece regulatory snapshot, August 2019
26th August 2019 - Regulatory reports |
Our latest look at the regulations governing CBD in Greece details what can be grown, what products are allowed on the market and what further regulations are proposed
CBD-Intel regulatory news in brief, 19th-23rd August 2019
26th August 2019 - Alerts , News analysis , Regulatory alerts roundup |
Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight
In the zone – Colombia’s promised new rules lead to optimism over exports
23rd August 2019 - News analysis |
A new government decree in Colombia is expected to boost the hemp/cannabis export market by as early as the end of 2019, leading to optimism about the industry in the country
New York State regulatory snapshot, August 2019
23rd August 2019 - Regulatory reports |
CBD and industrial hemp are quite tightly regulated in New York State, as detailed in this short regulatory report
Enforcement remains light: UK regulatory snapshot
23rd August 2019 - Regulatory reports |
In our latest look at the rules and regulations governing CBD in England, Wales and Scotland, we look at what can and can’t be produced or sold and what licences are required
Italians sell CBD flowers as ‘animal feed’ to avoid confused enforcement
21st August 2019 - News analysis |
Some Italian companies have begun to register CBD hemp flower products as animal feed in an attempt to avoid regulatory confusion and uneven enforcement in the country
Slovakia regulatory snapshot, August 2019
21st August 2019 - Regulatory reports |
Under Slovak law, CBD is classed as a psychotropic substance and as such it cannot be extracted, stored, or used for manufacture of final products without authorisation under the Narcotics Act
CannTrust’s future cast in doubt after renewed troubles with Health Canada
20th August 2019 - News analysis |
The future of one of Canada’s largest cannabis companies is hanging in the balance after a whistleblower and an unannounced inspection by Health Canada triggered a series of problems for CannTrust
Kannaway hopes to use Bulgarian licence as a doorway into EU markets
20th August 2019 - News analysis |
CBD supplier Kannaway says it has been granted licences confirming compliance with the law and permitting free sale of a product in an EU member state – Bulgaria – as well as in Russia
Mexico holds open talks in move towards legalisation of cannabis
19th August 2019 - News analysis |
The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate
CBD-Intel regulatory news in brief
19th August 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey
Holland & Barrett tests the water with health claims for new CBD range
16th August 2019 - News analysis |
The UK’s largest high street health food retailer is increasing the number of CBD products it sells with a new range – and with it testing the rules on health claims
First Jersey hemp licence issued – ‘a significant opportunity’ for island
14th August 2019 - News analysis |
Hemp can now be grown on the Channel Island of Jersey following the issuance of the first licence to harvest, process and store hemp flower in preparation for CBD extraction.
CBD vaping expected to continue growth, say stakeholders
13th August 2019 - News analysis |
CBD vaping stakeholders in Europe expect to see the category continue to grow – fuelled by unclear regulations over CBD as a food ingredient combined with a low barrier to entry
CBD-Intel bonus midweek regulatory alerts, 8th August 2019
8th August 2019 - News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe
Japan regulatory snapshot, August 2019
5th August 2019 - Regulatory reports |
Japanese law is easygoing on some aspects of the CBD market and very strict on others, as a result of the country’s rigorous regulation of cannabis
CBD-Intel regulatory news in brief
5th August 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa
UK hemp farmer claims Home Office delays caused crop destruction
2nd August 2019 - News analysis |
A UK hemp farming co-operative has told CBD-Intel of its plans to launch a campaign to raise support for legislative changes to support the UK CBD industry
Chile regulatory snapshot, July 2019
2nd August 2019 - Regulatory reports |
This report examines the somewhat ambiguous legal position of hemp and CBD products in Chile, where there is no clear legislative regime for CBD, and where isolated CBD is not a scheduled substance
MHRA enforces CBD rules with British store
1st August 2019 - News analysis |
A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health claims.
Epidyolex takes huge step toward EU licensing
31st July 2019 - News analysis |
A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.
Italy regulatory snapshot, July 2019
29th July 2019 - Regulatory reports |
In our latest regulatory snapshot, we look at the current situation in Italy — where taxes and rules have been changing regularly over recent times
China regulatory snapshot, July 2019
29th July 2019 - Regulatory reports |
CBD-Intel’s report on the regulatory status of CBD in China provides all you need to know about the present legal status of CBD, plus hemp cultivation and much more
CannTrust leaders axed, confusion in Italy: regulatory news in brief
29th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory news features items from Canada, New York, Texas, Nevada, Washington State, Italy and Portugal
No Euphoria here – Ireland recalls Dutch oil from sale over THC content
26th July 2019 - News analysis |
A batch of CBD oil has been removed from sale by authorities in the Republic of Ireland after it was found to contain THC
Curaleaf in hot water with FDA over ‘improper health claims’
25th July 2019 - News analysis |
The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety
Senate hearing raises hope of SAFE banking for US CBD industry
25th July 2019 - News analysis |
Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication
Poland’s bizarre rules mean CBD oil is taxed as food but labelled non-edible
25th July 2019 - News analysis |
The Polish CBD sector is beset by confusing regulation and uneven enforcement – but it does benefit from a reduced rate of VAT, below even that of prescription medical cannabis
FDA gathers in opposing strong views and cannabis-related anecdotes
25th July 2019 - News analysis |
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views
CBD-Intel regulatory news in brief
24th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium
Can CBD products really be food and drink to a hungry market?
24th July 2019 - News analysis |
Sales of water infused with CBD may be held back by doubts over whether the product is effective and also by regulation, recent reporting by CBD-Intel suggests
Is Serbia set to place ‘psychoactive’ CBD on the controlled list?
23rd July 2019 - News analysis |
A tough regulatory regime in Serbia may soon become even tougher as the Commission for Psychoactive Controlled Substances believes CBD should be a scheduled substance
Health Canada steps up vigilance, with clamps on Agrima and CannTrust
22nd July 2019 - News analysis |
Health Canada has revoked the licence of producer Agrima Botanicals and put a hold on product grown by CannTrust
CBD-Intel regulatory news in brief
22nd July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China
US senators push for law change to ease research into CBD and cannabis
18th July 2019 - News analysis |
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Italy’s Supreme Court explanation leaves ‘psychotropic effect’ unclear
18th July 2019 - News analysis |
Italy’s Supreme Court has published the reasoning behind its ruling that cannabis products are illegal except for those without psychotropic effects – without adding any clarity
CBD: a fragmented market in an uncertain regulatory landscape
17th July 2019 - News analysis |
From hummus to suppositories, the UK CBD market is highly fragmented, with over 700 brands available, as CBD-Intel managing director Tim Phillips explains in this presentation given at the Europe CBD Expo in London
Congressional pressure builds in favour of progress on CBD
17th July 2019 - News analysis |
Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon
It’s business as unusual over CBD in topsy-turvy Washington circles
15th July 2019 - News analysis |
CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise
European markets facing difficulties from inconsistent enforcement
15th July 2019 - Market reports |
Retailers selling CBD wares in Europe are currently facing multiple hurdles, with unclear legislation often leading to roughshod enforcement from local authorities
CBD-Intel regulatory news in brief
15th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam
CBD-Intel regulatory news in brief
11th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa
Texas regulatory snapshot, July 2019
10th July 2019 - Regulatory reports |
The Texas hemp plan, legalising the cultivation, handling and processing of hemp in the state, became law on 10th June – but would-be manufacturers are still having to wait
Podcast: Implications of the EU novel food regulation on the CBD food supplements sector
10th July 2019 - Podcasts , Resources |
Vitafood Insights invited CBD-Intel to participate in one of their podcast sessions to offer a comprehensive understanding of the regulatory landscape of CBD in Europe. CBD is dominating worldwide attention and it is essential for companies looking to launch CBD products in the dietary supplements and functional foods sectors to understand the current regulatory situation and possible future enforcement. Charlotte » Continue Reading.
